{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T22:40:44Z","timestamp":1775601644183,"version":"3.50.1"},"reference-count":27,"publisher":"The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Turk J Med Sci"],"published-print":{"date-parts":[[2017]]},"DOI":"10.3906\/sag-1610-82","type":"journal-article","created":{"date-parts":[[2017,6,17]],"date-time":"2017-06-17T09:17:25Z","timestamp":1497691045000},"page":"987-995","source":"Crossref","is-referenced-by-count":6,"title":["Rational design of rabies vaccine formulation for enhanced stability"],"prefix":"10.55730","volume":"47","author":[{"given":"Veysel","family":"KAYSER","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"FRAN\u00c7ON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herv\u00e9","family":"PINTON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Fran\u00e7ois","family":"SALUZZO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhardt L.","family":"TROUT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"34691","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)71060-6"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(02)00287-6"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-70060-6_2"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"4. Cox JH, Dietzschold B, Schneider LG. Rabies virus glycoprotein. II. Biological and serological characterization. Infect Immun 1977; 16: 754-759.","DOI":"10.1128\/IAI.16.3.754-759.1977"},{"key":"ref5","unstructured":"5. Dietzschold B, Cox J, Schneider G. Structure and function of rabies virus glycoprotein. Dev Biol Stand 1978; 40: 45-55."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-40-1-131"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-76-7-1541"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/096876899294724"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-1702(03)00075-3"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1006\/viro.2002.1429"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2007.01.093"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"12. Madora H, England J. Rabies virus protein synthesis in infected BHK-21 cells. J Virol 1977; 22: 102-112.","DOI":"10.1128\/JVI.22.1.102-112.1977"},{"key":"ref13","unstructured":"13. Public Health England. Human Rabies Vaccines. London, UK: Public Health England."},{"key":"ref14","unstructured":"14. Galazka A, Milstein J, Kartoglu U, Zaffran M. Temperature Sensitivity of Vaccines. WHO\/IVB\/06.10. Geneva, Switzerland: WHO; 2006."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.10540"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/jps.22276"},{"key":"ref17","unstructured":"17. Galazka A, Milstien J, Zaffran M. Thermostability of Vaccines. WHO\/GPV\/98.07. Geneva, Switzerland: WHO; 1998."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.06.031"},{"key":"ref19","unstructured":"19. Wiktor TJ, Atanasiu P, Bahmanyar M, Boegel K, Cox JH, Diaz AM, Fitzgerald EA, Kuwert E, Netter R, Selimov M et al. Comparison studies on potency tests for rabies vaccines. Dev Biol Stand 1978; 40: 171-178."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(88)90185-5"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"21. Michalski F, Parks NF, Sokol F, Clark HF. Thermal inactivation of rabies and other rhabdoviruses: stabilization by the chelating agent ethylenediaminetetraacetic acid at physiological temperatures. Infect Immun 1976; 14: 135-143.","DOI":"10.1128\/IAI.14.1.135-143.1976"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1006\/abio.2001.5210"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.7589\/0090-3558-41.3.549"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1080\/01652176.1996.9694637"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-14-1-33"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5320(72)90036-6"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"27. Lee KKH, Sahin YZ, Neeleman R, Trout BL, Kayser V. Quantitative determination of the surfactant-induced split ratio of influenza virus by fluorescence spectroscopy. Hum Vaccin Immunother 2016; 12: 1757-1765.","DOI":"10.1080\/21645515.2016.1141846"}],"container-title":["TURKISH JOURNAL OF MEDICAL SCIENCES"],"original-title":[],"deposited":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T07:18:41Z","timestamp":1655709521000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.tubitak.gov.tr\/medical\/vol47\/iss3\/41"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":27,"URL":"https:\/\/doi.org\/10.3906\/sag-1610-82","relation":{},"ISSN":["1300-0144","1303-6165"],"issn-type":[{"value":"1300-0144","type":"print"},{"value":"1303-6165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}